Literature DB >> 9821978

Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits.

A C Rice1, C L Floyd, B G Lyeth, R J Hamm, R J DeLorenzo.   

Abstract

PURPOSE: The role of N-methyl-D-aspartate (NMDA)-receptor activation on behavioral and cognitive changes after status epilepticus (SE) is unknown. In this study, behavioral and cognitive changes after SE were evaluated in the short and long term and in rats in which the NMDA receptor was inactivated during SE.
METHODS: Pilocarpine (350 mg/kg) was injected to induce SE. Inhibition of the NMDA receptor during SE was achieved with MK-801 (4 mg/kg). Seizure intensity during SE was monitored by electroencephalography (EEG). After SE, behavioral studies were performed to identify abnormal behavior by using behavioral tests adapted from Moser's functional observational battery. Cognitive changes were assessed by using the Morris Water Maze (MWM).
RESULTS: Pilocarpine-treated animals scored significantly higher on two of the behavioral tests: the Touch test and the Pick-Up test. These behavioral changes occurred very soon after SE, with the earliest changes observed 2 days after SE and persisting for the life of the animal. Inhibition of the NMDA receptor with MK-801 completely inhibited these behavioral changes under conditions that did not alter the duration of SE. In addition, pilocarpine-treated animals exhibited cognitive deficits as determined by using the MWM. Six weeks after SE, the animals displayed significantly longer latencies to locate the hidden platform on this test. The impaired performance on the MWM also occurred as early as 5 days after SE. These cognitive deficits were prevented in animals treated with MK-801 during SE.
CONCLUSIONS: The results indicate that behavioral and cognitive changes occur soon after SE, are permanent, and are dependent on NMDA-receptor activation during SE. NMDA-receptor activation may play an important role in causing cognitive and behavioral morbidity after recovery from SE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9821978     DOI: 10.1111/j.1528-1157.1998.tb01305.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  18 in total

1.  Rapamycin attenuates aggressive behavior in a rat model of pilocarpine-induced epilepsy.

Authors:  X Huang; J McMahon; Y Huang
Journal:  Neuroscience       Date:  2012-04-20       Impact factor: 3.590

Review 2.  Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy.

Authors:  Amy R Brooks-Kayal; Kevin G Bath; Anne T Berg; Aristea S Galanopoulou; Gregory L Holmes; Frances E Jensen; Andres M Kanner; Terence J O'Brien; Vicky H Whittemore; Melodie R Winawer; Manisha Patel; Helen E Scharfman
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

3.  Development of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of lethal paraoxon intoxication.

Authors:  Laxmikant S Deshpande; Dawn S Carter; Kristin F Phillips; Robert E Blair; Robert J DeLorenzo
Journal:  Neurotoxicology       Date:  2014-04-29       Impact factor: 4.294

Review 4.  Role of the calcium plateau in neuronal injury and behavioral morbidities following organophosphate intoxication.

Authors:  Laxmikant S Deshpande; Robert E Blair; Kristin F Phillips; Robert J DeLorenzo
Journal:  Ann N Y Acad Sci       Date:  2016-06-21       Impact factor: 5.691

5.  Proconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat.

Authors:  S Bröer; D Zolkowska; M Gernert; M A Rogawski
Journal:  Neuroscience       Date:  2013-07-29       Impact factor: 3.590

6.  Memantine attenuates cognitive impairments after status epilepticus induced in a lithium-pilocarpine model.

Authors:  S V Kalemenev; O E Zubareva; V V Sizov; V V Lavrent'eva; N Ya Lukomskaya; K Kh Kim; A V Zaitsev; L G Magazanik
Journal:  Dokl Biol Sci       Date:  2016-11-08

7.  Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits.

Authors:  Jerome Niquet; Roger Baldwin; Keith Norman; Lucie Suchomelova; Lucille Lumley; Claude G Wasterlain
Journal:  Epilepsia       Date:  2016-08-08       Impact factor: 5.864

8.  A cellular mechanism for dendritic spine loss in the pilocarpine model of status epilepticus.

Authors:  Jonathan E Kurz; Bryan J Moore; Scott C Henderson; John N Campbell; Severn B Churn
Journal:  Epilepsia       Date:  2008-05-08       Impact factor: 5.864

9.  Agonists and antagonists of metabotropic glutamate receptors: anticonvulsants and antiepileptogenic agents?

Authors:  Feng Ru Tang
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

10.  Altered phase precession and compression of temporal sequences by place cells in epileptic rats.

Authors:  Pierre-Pascal Lenck-Santini; Gregory L Holmes
Journal:  J Neurosci       Date:  2008-05-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.